i






Public Title Status Last Date Modified
A 26 Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial with a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 . . . Ongoing 15 May 2018
Immunogenicity and Safety of Tetravalent Dengue Vaccine Given in 1 , 2 , or 3 Dose Schedules (STAGE I) Followed by a Single Booster Injection of the Same Vaccine (STAGE II) 1 or 2 Years After the Last . . . Ongoing 13 Feb 2017
A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects with Neovascular Age-related Macular Degeneration . . . Pending 05 Dec 2018
LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE (LATITUDE)-TIMI 60 . . . Ongoing 05 May 2016
A 104-Week, Flexible-Dose, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Effectiveness of Lurasidone in Pediatric Subjects with Schizophrenia and Subjects with Irritabi . . . Ongoing 08 Dec 2016
A 12-month, phase III, randomized, double-masked, multicenter, active-controlled study to evaluate the efficacy and safety of two individualized regimens of 0.5 mg ranibizumab vs. verteporfin PDT in p . . . Ongoing 11 Mar 2015
A 12-week treatment, multi-center, randomized, doubleblind, parallel-group, placebo and active controlled study to assess the efficacy, safety, and tolerability of QVA149 (indacaterol maleate / glycop . . . Completed 11 Mar 2015
A 12-week treatment, randomized, blinded, double-dummy, parallel-group study to assess the efficacy, safety, and tolerability of NVA237 (50 µg o.d.) compared to tiotropium (18 µg o.d.) in patients w . . . Completed 03 Jan 2014
A 14 week, randomized, double-blind, multi-center, parallel group, active controlled study to evaluate the efficacy and safety of LCZ696 in comparison to olmesartan . . . Completed 11 Nov 2013
A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor vs mycophenolate with standard calcineurin inhibitor . . . Ongoing 11 Mar 2015
A 24-week phase III randomized, double-blind, parallel group study to evaluate the efficacy and safety of twice daily oral administration of empagliflozin + metformin compared with the individual comp . . . Completed 01 Sep 2015
A 24-week phase III randomized, double-blind, parallel group study to evaluate the efficacy and safety of twice daily oral administration of empagliflozin + metformin compared with the individual comp . . . Completed 01 Sep 2015
A 26 week, randomized, active-controlled safety study of double-blind formoterol fumarate in free combination with an inhaled corticosteroid versus an inhaled corticosteroid in adolescent and adult pa . . . Terminated 05 May 2016
A 26-week treatment, randomised, double-blind, placebo-controlled, parallel group study to assess the efficacy, safety and tolerability of NVA237 (50 µg o.d.) in patients with chronic obstructive pul . . . Completed 03 Jan 2014
A 52-week treatment, multi-center, randomized, doubleblind, double dummy, parallel-group, active controlled study to compare the effect of QVA149 (indacaterol maleate / glycopyrronium bromide) with sa . . . Ongoing 11 Mar 2015
A 6-month safety and benefit study of inhaled fluticasone, propionate/ salmeterol combination versus inhaled fluticasone, propionate in the treatment of 6,200 pediatric subjects 4-11 years old with pe . . . Completed 18 Dec 2018
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects with Schizophrenia . . . Ongoing 09 Aug 2016
A Blinded Extension to 5 Years of a Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fracture in Osteoporotic Pos . . . Completed 05 Jun 2017
A Clinical Outcomes Study to compare the effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease ( . . . Completed 14 Sep 2016
A Clinical Trial To Evaluate Efficacy For Patients With Primary Liver Cancer Scheduled To Be Treated With Radiofrequency Ablation (RFA). This Study Will Compare RFA Plus An Investigational Drug Of Lip . . . Ongoing 18 Mar 2015
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects with Lupus Nephritis . . . Terminated 10 Aug 2016
A Double-Blind Randomized Controlled Trial in the Treatment of Verruca Vulgaris using Intralesional Tuberculin Purified Protein Derivative . . . Completed 08 Mar 2018
A Glucose-6-Phosphate Dehydrogenase (G6PD) enzyme assay validation protocol Ongoing 01 Sep 2014
A Long-Term Study of SM-13496 in Patients with Bipolar I Disorder Ongoing 20 Jun 2016
A Long-term, Safety, Tolerability, and Efficacy Study of Retigabine Immediate-release (IR) in Asian Adults With Partial Onset Seizures . . . Terminated 17 Sep 2013
©2021 HERDIN PLUS. All rights reserved. | Contact Us | Keep up to date